Back

MIRA Pharmaceuticals shares jump 16.87% on MIRA-55 toxicology results

Verifying
  • MIRA Pharmaceuticals reported positive MIRA-55 toxicology findings from seven-day rat and dog studies.
  • Shares rose 16.87% to $0.90 on Tuesday, according to Benzinga Pro data.
  • MIRA targets an FDA Investigational New Drug application in the first quarter of 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.